Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $0.74
Key levels
Resistance$0.74
Resistance$0.67
Support$0.60
Latest news & SEC filings
EarningsCreative Medical Technology Holdings Posts 3Q 2026 Results
ProductCreative Medical Technology Reports Ultrasome Knee Osteoarthritis Study Data
All CELZ news →Creative Medical Technology is a clinical-stage biotechnology company developing regenerative cell therapies. Its programs target Type 1 diabetes, chronic lower back pain, erectile dysfunction, female infertility and other conditions, using platforms such as AlloStem, ImmCelz and StemSpine. The company also works on reprogrammed stem cell lines and artificial intelligence-assisted research with partners. It operates in the United States.
Based on the company's 10-K filed Mar 20, 2026.
Nasdaq · Healthcare
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CELZ.
Start Free Trial →Valuation Verdict
UNDERVALUED
Methods Used
P/B
Fair Value
$5.69
47
Moat Score
NARROW
5/9
Piotroski Score
-11.1
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Warbington Timothy | director officer 10% owner | Buy | 1,000,000 | - | Sep 24, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
-45.5%
3yr Revenue CAGR
-59.2%
EPS Growth YoY
32.08%
FCF Growth YoY
N/A%
Revenue Trend
ACCELERATING
SEPT Investing tracks real-time dark pool institutional trades for CELZ, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 22:08:48 | $0.61 | 3,000 | $$2K | SELL |
| 22:07:00 | $0.61 | 2,000 | $$1K | SELL |
| 19:19:54 | $0.62 | 5,425 | $$3K | SELL |
| 18:49:30 | $0.63 | 2,501 | $$2K | BUY |
| 17:11:06 | $0.63 | 4,500 | $$3K | BUY |
5 dark pool trades shown · $$11K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings intelligence, and a complete investment thesis with entry and exit recommendations.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) is at $0.62, up 2.07% (+$0.01) at the Nov 6, 2026 close.
Latest CELZ news — Nov 7, 2026: Creative Medical Technology Holdings Posts 3Q 2026 Results · Oct 20, 2026: Creative Medical Technology Reports Ultrasome Knee Osteoarthritis Study Data
CELZ last reported on Aug 7, 2026: EPS -$0.41 vs -$0.39 expected — a miss of 5.1%.
Support: $0.60. Resistance: $0.67, $0.74, $1.50.
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
Nov 7, 2026: Creative Medical Technology Holdings Posts 3Q 2026 Results · Oct 20, 2026: Creative Medical Technology Reports Ultrasome Knee Osteoarthritis Study Data